News
GSK shares fell after a Food and Drug Administration advisory committee voted against approval of the company's Blenrep drug, a setback for its bid to reintroduce the blood-cancer treatment in the U.S ...
The low-cost gym giant is coming off four consecutive months of higher foot traffic despite raising its signature membership price to $15 from $10 last summer. Galaxy Digital Sees Demand Surge as U.S.
AI inference attacks drain enterprise budgets, derail regulatory compliance and destroy new AI deployment ROI.
GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine ...
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Investors in GSK plc (Symbol: GSK) saw new options begin trading today, for the August 8th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GSK options chain ...
AnaptysBio’s lead drug rosnilimab showed promise in RA, but lack of a Phase 3 plan and limited pipeline raise concerns. Find ...
Senator Maggie Hassan is investigating GSK's discontinuation of Flovent HFA, citing increased hospitalizations, higher drug costs, and lost Medicaid rebates.
In the segment, while products like Nucala and Dovato are key top-line drivers, new long-acting HIV medicines, Cabenuva and ...
Warren Buffett is one of the most renowned investors of our time. So, it’s easy to forget that he was once a beginner too.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results